EU Conditionally OKs Private Equity Buy of ConvaTec for $4.1 Billion

July 16, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BRUSSELS, July 16 (Reuters) - Nordic Capital Fund VII and Avista Capital Partners won conditional approval from the European Commission to buy the ConvaTec wound and ostomy care business of Bristol-Myers Squibb Co for $4.1 billion.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Europe